Home» Circulars» Viewcirculars Back
 
Invitation to Stakeholders’ for EFDA Ethiopia Web Conference on Accelerating Marketing Authorization of Health products on 16th April 2026 at 1:30 PM IST
 

 

PxlNwLtrHeaderLogo

PXL/HO/Cir-001/2026-27                                                                                     Date: 08-04-2026

Hyderabad

Subject: Invitation to Stakeholders’ for EFDA Ethiopia Web Conference on Accelerating Marketing Authorization of Health products on 16th April 2026 at 1:30 PM IST.


We would like to bring to the kind information of member companies that EFDA, Ethiopia is organising a Web Conference on “Accelerating Marketing Authorization of Health Products in Ethiopia”

 

The Ethiopian Food and Drug Authority [EFDA] is committed to enhancing public health by improving access to safe, high-quality, and efficacious medicines. Over the past few years, EFDA has made significant strides in transforming the regulatory landscape to make it more efficient, transparent, and investor-friendly.

 

To support manufacturers in navigating the regulatory landscape, and to streamline the approval process for Health products, we are hosting an exclusive webinar. The objective of this session is to provide direct insights into the Country’s regulatory requirements, address common pitfalls (bottlenecks) in dossier submission, and accelerate the Marketing Authorization process.

 

Webinar Details:

 

Topic: Strategies for Successful Marketing Authorization Submissions

Date: 16 April 2026

Time: 1:30 PM to 5:30 PM (IST)

Platform: Zoom

 

Registration Link:

https://lnkd.in/dDADmGiG

 

Agenda Highlights:

 

  • Regulatory Updates: Overview of Regulatory Requirements for Health Product Dossier submission.
  • EFDA Strategy for Streamlining Dossier Approval: Strategy for expedite Marketing Authorization of essential medicine.
  • Market Access Opportunities: Insights into essential medicine needs.
  • Live Q&A Session: Direct interaction with regulatory reviewers.

 

The webinar will also address an overview of regulatory requirements for health product dossier submission and provide insights into market access opportunities, focusing on current and priority essential medicine needs.

 

We request member companies to take advantage of this opportunity and participate in the Webinar on April 16, 2026, from 1:30 PM to 5:30 pm India time.

 

For more information, please contact : Mengistu Legesse: mlegesse@efda.gov.et +251911950615, Fasil Hailemariam: fhailemariam@efda.gov.et +251923145480, Daniel Takiel: dtakele@efda.gov.et, +251911150099

 

With regards,

 

Raja Bhanu

Director General